Cytel

Have you already read the FDA's new draft guidance on DMCs? 🤔Let's revisit David Kerr's blog post on this to refresh your memory and see what changes might be upcoming! Key changes include enhanced roles, better communication, and risk-based monitoring. It l for sponsors, researchers, and regulators. Read more: https://hubs.ly/Q02HDkXQ0 #ClinicalTrials #FDA #DMC #Healthcare

Team Cytel is present at the ISCB Conference in Thessaloniki, making statistics cool in the middle of a heatwave with various presentations and posters!😎 Cytel's co-founder Cyrus Mehta presented “Graph based adaptive group sequential designs for trials with multiple endpoints” in an invited session about innovative complex adaptive designs. And colleagues Valeria Mazzanti, Boaz Adler and Pantelis Vlachos presented two posters: “Optimizing Oncology Clinical Trial Strategies: Comparative Analysis of Single Versus Dual Endpoint Designs” and “Integrating Market Access Considerations in Clinical Trial Design: Leveraging Cloud-Native Software for Holistic Optimization” #Statistics #ClinicalTrials #MAMS #OncologyTrials #ClinicalTrialDesign

ANNOUNCEMENT - We are excited to share that Cytel has formed a strategic partnership with OneMedNet (ONMD), a pioneer in clinical and imaging Real-World data solutions. This collaboration marks a significant step forward in our commitment to advancing human data science through innovative analytics and insights. Massoud Toussi, Vice President, Global Head of Real-World Evidence expresses: “As a human data science company, we’re thrilled to announce our strategic partnership with OneMedNet. Their unique access to data from imaging devices, combined with their innovative iRWD platform for collecting additional clinical data, aligns perfectly with our mission. This collaboration will empower us to deliver additional valuable solutions to our clients and drive meaningful impact in our industry.” Read the full announcement here: https://hubs.ly/Q02HrChz0 #RWE #RWA #RealWorldData #AI

Did you get last weeks poll correct? We have done over 500 IDMC over the past 10 years across all major therapeutic areas 🎉 Our Axio® Independent DMC provides comprehensive protection of patient safety and trial integrity, managed by professionals trained specifically for independent statistical analysis. With over 45 years of experience across industry, academia, and government projects globally, Axio® is widely recognized as a world-leading provider of DMC support services. Discover more about Axio: https://hubs.ly/Q02HpjsM0 #DMC #IDMC #DataMonitoring #ClinicalTrials #OncologyTrials #RareDiseaseTrials

🔎 For our latest Fun Facts Friday we're diving deeper into Independent Data Monitoring Committees (IDMC)! 💡 Want to know more, discover how we can help with our Axio Data Monitoring Committees: https://lnkd.in/e9NYwttB #DataMonitoring #ClinicalData #DMC #IDMC #ClinicalTrials

Curious how a patient-first approach can transform your clinical research? In our latest blog, Benjamin Piske and Cedric Marchand offer valuable insights on integrating patient journey-centric study designs into clinical trials from a CRO perspective. Read the full article to learn more 👉https://hubs.ly/Q02H3ltz0 #ClinicalTrials #PatientEngagement #CRO #ClinicalResearch #PatientExperience #adaptivetrialdesigns #DecentralizedTrials #datastrategy #LifeSciences #Pharma #biotech

Are you as excited for JSM 2024 as we are? 🎉Visit booth 505 to discover how Cytel’s cutting-edge solutions can transform clinical research with innovative trial designs, real-world evidence, and data science. Our expert team will be on hand to discuss your specific challenges and demonstrate how our software can streamline your workflows and improve outcomes. Book your meeting now already: https://hubs.ly/Q02GV-hm0 #JSM #BioStatistics #Statistics #OncologyTrials #RareDiseaseTrials #EastHorizon

🔎 Poll answer time! 🔎 Only 21% had it correct! Over the last ten years, Cytel has been involved in over 6000 phase I-III trials 👨🔬👩🔬 Want to know more? 👉 https://hubs.ly/Q02GxLzx0

🚀 Ready to dive deeper into the world of basket trials? Join our upcoming webinar on August 1, 2024, at 9 AM ET / 3 PM CET to explore cutting-edge advancements in basket trials for oncology drug development! Learn how Bayesian methods can enhance trial precision and efficiency. 📊 Key Topics: Exchangeability in treatment effects Degrees of information borrowing Simulation studies and real-world impact Examples from phase I and II trials 📢 Speaker: Yuan Ji, Professor of Biostatistics at The University of Chicago 👉 Register Now: https://hubs.ly/Q02GxHYW0 #Oncology #ClinicalTrials #BayesianMethods #Biostatistics #Webinar #DrugDevelopment

It's again time for our Fun Friday Facts! 🎉 Today we're diving deeper into some of our data facts! More specifically all the different trials we've been involved in! 👨🔬 As always, want to read up before you answer? Check out our new website www.cytel.com